Altered distribution of heparan sulfate proteoglycans in psoriasis

Acta Dermato-Venereologica

Volumn 77, Issue 2, 1997, Pages 105-109

  Seyger, M M B ^a   Van Den Born, J ^a   Schalkwijk, J ^a   Van De Kerkhof, P C M ^a   De Jong, E M G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

basement membrane; dermo epidermal junction; immunohistochemical; normal skin; uninvolved psoriasis

Indexed keywords

HEPARAN SULFATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PSORIASIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BASEMENT MEMBRANE; CULTURE TECHNIQUES; FEMALE; HEPARITIN SULFATE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PSORIASIS; TISSUE DISTRIBUTION;

EID: 0030910125     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. van de Kerkhof PCM, Bos JD. Pathogenetic aspects of psoriasis. Clin Dermatol 1995; 13:97-190.(Abstract.)
2. Macdonald Hull S, Goodfield M, Wood EJ, Cunliffe WJ. Active and inactive edges of psoriatic plaques: identification by tracing and investigation by laser Doppler flowmetry and immunocytochemical techniques. J Invest Dermatol 1989; 92: 782-785.
3. van de Kerkhof PC, van Rennes H, de Grood R, Bauer FW, Mier PD. Metabolic changes at the margin of the spreading psoriatic lesion. Br J Dermatol 1983; 108: 647-652.
4. De Jong EMGJ, Schalkwijk J, van de Kerkhof PCM. Epidermal proliferation and differentiation, composition of the inflammatory infiltrate and the extracellular matrix in the margin of the spreading psoriatic lesion. Eur J Dermatol 1991; 1: 221-227.
5. Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem 1989; 180: 487-502.
6. Briggaman RA. Biochemical composition of the epidermal-dermal junction and other basement membrane. J Invest Dermatol 1982; 78: 1-6.
7. Woodley DT. Importance of the dermal-epidermal junction and recent advances. Dermatologica 1987; 174: 1-10.
8. Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 1990; 4: 1577-1590.
9. Mondello MR, Califano L, Cannavo SP, Di Mauro D, Guarneri B, Magaudda L, et al. Psoriasis and cyclosporin: immunohistochemical aspects of the basement membrane. Acta Derm Venereol (Stockh) 1994; Suppl 186: 96-98.
10. el Sherif AI, Krupinski A, Majewski S, Jablonska S. Leukocyte-extracellular matrix interactions in psoriasis. Int J Dermatol 1994; 33: 371-373.
11. Fyrand O. Studies on fibronectin in the skin. II. Indirect immunofluorescence studies in psoriasis vulgaris. Arch Dermatol Res 1979; 266: 33-41.
12. Glinski W, Jarzabek Chorzelska M, Kuligowski M, Pierozynska Dubowska M, Glinska Ferenz M, Jablonska S. Basement membrane zone as a target for human neutrophil elastase in psoriasis. Arch Dermatol Res 1990; 282: 506-511.
13. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992; 6: 861-870.
14. Gallagher JT, Lyon M, Steward WP. Structure and function of heparan sulphate proteoglycans. Biochem J 1986; 236: 313-325.
15. Battaglia C, Mayer U, Aumailley M, Timpl R. Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. Eur J Biochem 1992; 208: 359-366.
16. Ruoslahti E. Proteoglycans in cell regulation. J Biol Chem 1989; 264: 13369-13372.
17. Rajka G, Thune P. The relationship between the course of psoriasis and transepidermal water loss, photoelectric plethysmography and reflex photometry. Br J Dermatol 1976; 94: 253-261.
18. Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 1994; 130: 452-456.
19. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden-JH. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. J Histochem Cytochem 1994; 42: 89-102.
20. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate. Lab Invest 1991; 65: 287-297.
21. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 1992; 41: 115-123.
22. van den Born J, Gunnarsson K, Bakker MA, Kjellen L, Kusche Gullberg M, Maccarana M, et al. Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 1995; 270: 31303-31309.
23. Tammi RH, Hyyrylainen AM, Maibach HI, Tammi MI. Ultrastructural localization of keratinocyte surface associated heparan sulphate proteoglycans in human epidermis. Histochemistry 1987; 87: 243-250.
24. Pinkus H, Mehregan AH. The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Dermatol 1966; 46: 109-116.
25. Verschoore M, Kowalewski C, Chorzelska MJ, Bernard BA, Darmon YM. Intraepidermal leakage of plasma proteins after tape stripping of normal skin and uninvolved psoriatic skin. Br J Dermatol 1990; 122: 391-397.
26. Termaat RM, Brinkman K, van Gompel F, van den Heuvel LP, Veerkamp JH, Smeenk RJ, et al. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA histone complexes. J Autoimmun 1990; 3: 531-545.
27. Kramers C, Hylkema MN, van Bruggen MC, van de Lagemaat R, Dijkman HB, Assmann KJ, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994; 94: 568-577.
28. Diamond MS, Alon R, Parkos CA, Quinn MT, Springer TA. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18). J Cell Biol 1995; 130: 1473-1482.
29. Aumailley M, Battaglia C, Mayer U, Reinhardt D, Nischt R, Timpl R, et al. Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int 1993; 43: 7-12.
30. Gay S, Kresina TF, Gay R, Miller EJ, Montes LF. Immunohistochemical demonstration of basement membrane collagen in normal human skin and in psoriasis. J Cutan Pathol 1979; 6: 91-95.
31. Cox AJ. The dermal-epidermal junction in psoriasis. J Invest Dermatol 1969; 53: 428-435.
32. Stow JL, Farquhar MG. Distinctive populations of basement membrane and cell membrane heparan sulfate proteoglycans are produced by cultured cell lines. J Cell Biol 1987; 105: 529-539.
33. Jalkanen M, Rapraeger A, Bernfield M. Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins. J Cell Biol 1988; 106: 953-962.
34. Sanderson RD, Hinkes MT, Bernfield M. Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 1992; 99: 390-396.
35. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 1995; 128: 673-685.
36. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995; 128: 687-698.